Stellate Ganglion Block in Children With Autistic Disorder

Launched by COPKA SONPASHAN · Mar 19, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called stellate ganglion block to see if it can help improve symptoms in children with Autistic Disorder. The main question is whether this treatment can make a difference in how these children behave and interact. In the study, children diagnosed with Autistic Disorder will be divided into two groups: one group will receive the stellate ganglion block while the other group will continue with their usual therapy. Researchers will compare the children's progress in both groups before and after the treatment using a special rating scale designed for autism.

To be eligible for this trial, children need to be between 4 and 8 years old and have a diagnosis of Autistic Disorder. They must not have any other serious medical or developmental issues that could affect the study. This trial is not currently recruiting participants, but it aims to provide valuable insights into whether this treatment can help young children with autism. If you're considering this for your child, it's important to discuss it with your healthcare provider to understand all the options available.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed as Autistic Disorder.
• • Aged between 4 years old and 8 years old.
• • No contraindications to stellate ganglion block.
• Exclusion Criteria:
• • Other significant physical or neurodevelopmental disorders.
• • Other significant medical conditions